Laboratory Solutions was Avantor’s largest segment in fiscal 2025, bringing in $8.80B of $13.10B (67%).
| Segment | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Laboratory Solutions | $10.00B | $9.48B | $9.22B | $8.80B | |||||
| Americas | — | — | — | — | |||||
| Europe | — | — | — | — | |||||
| Bioscience Production | $5.02B | $4.46B | $4.35B | $4.31B | |||||
| Amea | — | — | — | — | |||||
| Total | $15.02B | $13.93B | $13.57B | $13.10B |
Avantor brought in $13.10B from its two segments in fiscal 2025, the year ended December 31, 2025. That was down 3.4% from $13.57B in fiscal 2024. Laboratory Solutions was the largest at $8.80B (67.1%), ahead of Bioscience Production at $4.31B (32.9%).
Compared with fiscal 2024, Bioscience Production fell 1.0% to $4.31B and Laboratory Solutions fell 4.6% to $8.80B. From fiscal 2022 to 2025, combined revenue from these segments fell from $15.02B to $13.10B, a compound annual decline of 4.5%. Laboratory Solutions' share of the total rose from 66.6% to 67.1%.
Proprietary was Avantor’s largest product and service line in fiscal 2025, bringing in $6.90B of $13.10B (53%).
| Product and Service | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Proprietary | $8.05B | $7.44B | $7.23B | $6.90B | ||||
| Proprietary Materials Consumables | — | — | — | — | ||||
| Third-Party | $6.98B | $6.49B | $6.34B | $6.21B | ||||
| Third Party Materials Consumables | — | — | — | — | ||||
| Equipment Instrumentation | — | — | — | — | ||||
| Services Specialty Procurement | — | — | — | — | ||||
| Total | $15.02B | $13.93B | $13.57B | $13.10B |
Avantor brought in $13.10B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 3.4% from $13.57B in fiscal 2024. Proprietary was the largest at $6.90B (52.6%), ahead of Third-Party at $6.21B (47.4%).
Compared with fiscal 2024, Third-Party fell 2.1% to $6.21B and Proprietary fell 4.6% to $6.90B. From fiscal 2022 to 2025, combined revenue from these lines fell from $15.02B to $13.10B, a compound annual decline of 4.5%. Proprietary's share of the total fell from 53.6% to 52.6%.
United States was Avantor’s largest region in fiscal 2025, bringing in $6.56B of $13.10B (50%).
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $8.56B | $7.41B | $7.10B | $6.56B | |||||
| All Other Countries | $6.47B | $6.52B | $6.47B | $6.55B | |||||
| Other Countries In Europe | — | — | — | — | |||||
| Germany | — | — | — | — | |||||
| Total | $15.02B | $13.93B | $13.57B | $13.10B |
Avantor brought in $13.10B from its two regions in fiscal 2025, the year ended December 31, 2025. That was down 3.4% from $13.57B in fiscal 2024. United States was the largest at $6.56B (50.1%), ahead of All Other Countries at $6.55B (49.9%).
Compared with fiscal 2024, All Other Countries grew 1.2% to $6.55B, while United States fell 7.6% to $6.56B. From fiscal 2022 to 2025, combined revenue from these regions fell from $15.02B to $13.10B, a compound annual decline of 4.5%. United States' share of the total fell from 56.9% to 50.1%.
Avantor (AVTR) reports its revenue by segment, by product and service and by geography. In fiscal 2025, Laboratory Solutions was its largest segment, bringing in $8.80B (67.1% of the total), followed by Bioscience Production at $4.31B (32.9%).
Laboratory Solutions was Avantor's largest segment in fiscal 2025, bringing in $8.80B, or 67.1% of the $13.10B total across its two segments.
Proprietary was Avantor's largest product and service line in fiscal 2025, bringing in $6.90B, or 52.6% of the $13.10B total across its two product and service lines.
United States was Avantor's largest region in fiscal 2025, bringing in $6.56B, or 50.1% of the $13.10B total across its two regions.
All Other Countries grew faster than United States in fiscal 2025, up 1.2% from $6.47B to $6.55B. United States fell 7.6% to $6.56B.
Every figure comes from Avantor's annual financial filings, as reported. Each line keeps the name Avantor gives it, and years follow its fiscal calendar.
Avantor's revenue by segment goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.